Cytek Biosciences 2024 annual meeting results: all proposals approved by shareholders

Cytek Biosciences, Inc.

Elected Wenbin Jiang and Michael Holder as Class III directors with 64.2M and 70.3M votes for, respectively.
Advisory vote on executive compensation approved: 63.5M for, 10.5M against, 78.9K abstentions.
Ratified Deloitte & Touche LLP as independent auditor for FY2024: 94.1M for, 2.3M against, 656.7K abstentions.
Approximately 74% of outstanding shares (97.1M of 131.3M) represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.